Invesco Ltd. lowered its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 73.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 214,026 shares of the company's stock after selling 597,545 shares during the quarter. Invesco Ltd. owned 0.09% of Oscar Health worth $2,877,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also modified their holdings of OSCR. KBC Group NV raised its position in shares of Oscar Health by 56.1% during the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock worth $96,000 after acquiring an additional 2,555 shares in the last quarter. ORG Wealth Partners LLC acquired a new stake in shares of Oscar Health during the 4th quarter worth about $100,000. Alberta Investment Management Corp acquired a new stake in shares of Oscar Health during the 4th quarter worth about $138,000. Virtu Financial LLC acquired a new stake in shares of Oscar Health during the 4th quarter worth about $140,000. Finally, Potentia Wealth purchased a new position in Oscar Health during the 4th quarter worth approximately $141,000. Hedge funds and other institutional investors own 75.70% of the company's stock.
Analyst Upgrades and Downgrades
Separately, Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their target price for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $20.21.
Read Our Latest Stock Report on OSCR
Oscar Health Stock Performance
Shares of OSCR stock opened at $12.59 on Tuesday. The stock has a fifty day moving average price of $13.49 and a 200 day moving average price of $14.76. The stock has a market cap of $3.15 billion, a PE ratio of -629.19 and a beta of 1.75. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73.
Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Sell-side analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.
Oscar Health Profile
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.